A validated 8-question screening tool for obstructive sleep apnoea (OSA) risk.
Answer each question with Yes or No. Each "Yes" scores 1 point. Your responses are completely private.
Obstructive sleep apnoea (OSA) is a condition where the upper airway repeatedly collapses during sleep, causing breathing to stop briefly (apnoeas) or become very shallow (hypopnoeas). This leads to fragmented sleep, drops in blood oxygen, and excessive daytime sleepiness.
OSA is extremely common — it affects an estimated 9% of Australian adults, but up to 80% of moderate-to-severe cases remain undiagnosed. Risk increases with age, male sex, obesity, and certain facial structures.
Untreated OSA is associated with increased risk of hypertension, heart attack, stroke, type 2 diabetes, depression, motor vehicle accidents, and workplace injuries.
If the STOP-Bang suggests intermediate or high risk, your GP may refer you for a sleep study. There are two types:
Home sleep study (Level 3): A portable device worn overnight at home. It records breathing, oxygen levels, and body position. Medicare rebates may apply with a GP referral.
In-lab polysomnography (Level 1): An overnight stay at a sleep lab with comprehensive monitoring. This is the gold standard but is usually reserved for complex cases.
Treatment options include: CPAP (continuous positive airway pressure) — the most effective treatment for moderate-to-severe OSA; mandibular advancement splints (dental devices); weight loss; positional therapy (avoiding sleeping on your back); and in some cases, surgery.
The STOP-Bang questionnaire was developed by Dr Frances Chung at the University of Toronto. It was originally designed for preoperative screening but is now widely used in primary care and sleep medicine.
Validation studies show high sensitivity: a score of ≥3 identifies 93% of patients with moderate-to-severe OSA, and a score of ≥5 identifies patients at very high risk.
Source: Chung F et al. Anesthesiology 2008;108:812-821.